Fatty Acids, Omega-6
Research stageAlso known as OMEGA-6 FATTY ACIDS, Omega 6 acids, Omega 6 fatty acids, n-6 fatty acids.
Recent clinical, regulatory, research and industry developments relating to this drug.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Nature communications1
- Nutrients1
- Arita M1
- Calder PC1
- Djuricic I1
- Drucker DJ1
- Ichimura A1
- Igarashi M1
- Irie J1
- Itoh H1
- Graduate School of Agriculture1
- Graduate School of Medicine1
- Graduate School of Pharmaceutical Sciences1
- Keio University1
- Laboratory for Metabolomics1
- Laboratory of Physiology1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Fatty Acids, Omega-6 in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature